(Q83821245)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21479635%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

title

Bevacizumab plus gemcitabine and oxaliplatin as first-line therapy for metastatic or locally advanced pancreatic cancer: a phase II trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21479635%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference

phase II clinical trial

1 reference

1 reference

1 reference

James Lewis Abbruzzese

11

object named as

James L Abbruzzese

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21479635%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

author name string

David Fogelman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21479635%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Mehrdad Jafari

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21479635%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Gauri R Varadhachary

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21479635%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Henry Xiong

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21479635%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Susie Bullock

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21479635%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Harold Ozer

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21479635%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

E Lin

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21479635%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Jeffrey Morris

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21479635%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Patti Cunningham

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21479635%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Bronwyn Bennett

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21479635%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Robert A Wolff

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21479635%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

publication date

9 April 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21479635%20AND%20SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

28 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21479635%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

volume

68

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21479635%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21479635%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

page(s)

1431-1438

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21479635%20AND%20SRC:MED&resulttype=core&format=json